Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nubrace is a multi-ingredient nutritional supplement developed and marketed by Rebrace Pharmaceuticals. It is formulated to support a range of physiological functions, including bone strength, antioxidant defense, glucose metabolism, nerve function, and red blood cell production. The product typically contains a combination of methylcobalamin (a form of Vitamin B12), alpha-lipoic acid (a potent antioxidant), folic acid, and pyridoxine (Vitamin B6). These ingredients work synergistically to promote nerve regeneration, reduce oxidative stress, and support metabolic health. Nubrace is approved for use as a dietary supplement and is primarily indicated for individuals with nutritional deficiencies or metabolic disorders such as diabetic neuropathy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nubrace.